Pitfalls of a Non-Integrated Drug Development Process
When your company decides to explore options to develop your drug product, there are endless possibilities. However, this excitement is often quickly...
1 min read
Name: Elsie Melsopp, Ph.D.
Alcami Site: Wilmington, NC
How long have you been with Alcami?
I joined the company on March 17, 2017.
What is your role?
I lead the solids formulation development group, which is part of development services at our OSD manufacturinte site in Wilmington, NC.
What is the most rewarding part of your job?
Sharing the success of our customers and contributing to the pharmaceutical sciences.
What are your team’s latest achievements?
- A formulation platform for controlled release
- Mini-tablet technology suitable for a wide variety of applications such as: multi-particulates for IR and CR delivery, orally disintegrating tablets, pediatrics or geriatric oral dosage forms.
How do you see those accomplishments affecting the pharmaceutical industry?
Alcami offers product lifecycle options to the pharma industry. We innovate, continually developing new tools and programs to assist with the development of a new or existing (old) drug substance. By extending the release of a drug product or diversifying the oral administration, side effects are reduced and efficacy can be improved.